Skip to main content

Glaucoma, Open Angle, Primary

OMIM ID:

?

Glaucoma, Open Angle, Primary

Alternate Names

chronic simple glaucoma
CSG
open angle glaucoma
OAG
POAG

Defective Genes

MYOC

Clinical Characteristics

Ocular Features

It has long been known from both clinical and genetic criteria that the disease called glaucoma is a heterogeneous condition. The common denominator is considered to be an optic neuropathy for which the primary risk factor is an elevation of intraocular pressure. However, the well-known clinical profile of glaucomatous retinal and optic nerve damage can also be found among patients without increased IOP and for these the cause remains elusive.  Ultimately, damage to retinal neurons and their axons result in loss of visual field and optic nerve volume with eventual blindness if untreated.

Systemic Features

No systemic abnormalities are consistently associated with primary open angle glaucoma.  However, glaucoma occurs in a large number of ocular and systemic disorders as well as chromosomal aberrations and in many such conditions there are anatomic abnormalities in the anterior chamber angle.  A variety of mainly anecdotal risk factors such as obesity, smoking, diabetes, migraines, stress and cardiovascular disease have been reported but their causative relationships have not been established.

Genetics

Inheritance

Primary open angle glaucoma likely consists of a collection of disorders resulting from an optic neuropathy.  Based on family data and ethnic distribution there can be little doubt that genes influence susceptibility to this disease.  In fact, 13 types have been described based on the unique chromosomal locations of mutations that have been associated with each.   Mutations in MYOC (1q23-q24) are responsible for a substantial proportion of POAG cases known as GLC1A through as yet unknown mechanisms.  Others types labeled GLC1B through GLC1O may result from specific mutations located on 10 different chromosomes.  In the absence of pedigrees with typical Mendelian inheritance patterns, it is reasonable to consider that the genes reported to be associated with POAG so far simply confer susceptibility to the optic neuropathy characteristic of clinical glaucoma (for further discussion see 137760).  Unidentified environmental factors in combination with other genes in individual genomes likely determine the degree of susceptibility in each person. 

Treatment & Management

Lowering of intraocular pressure remains the only clinical treatment available to lower the risk of POAG.  Unfortunately, this is not always effective, especially when the intraocular pressure is not significantly elevated.  There are no infallible guidelines for optimum pressure control and the therapy regimen must be tailored by follow-up monitoring of visual field and optic cup changes.  Once established, it is a lifelong disorder that requires active management.

Early detection is important in the management of glaucoma.  It is largely a ‘silent’ disease and the eye care professional cannot assume that absence of symptoms correlates with absence of disease.  A family history of glaucoma, especially in first degree relatives, as well as African American, Native American, and Hispanic ethnicity, and increased age are associated with an elevated risk of open angle glaucoma.  Patients belonging to such high risk groups should be monitored with regular examinations.

Selected Resources

Publications

Displaying 1 - 4 of 4

Open-Angle Glaucoma

PubMedID: 8455668

The distinction between juvenile and adult-onset primary open-angle glaucoma

PubMedID: 8554064

The Search for Glaucoma Genes — Implications for Pathogenesis and Disease Detection

PubMedID: 9535674

Variants in the PRPF8 Gene are Associated with Glaucoma

PubMedID: 28707069